Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR New Investigator

McGill University

$300,000.00

Identification and characterization of novel substrates of the mammalian target of rapamycin complex 1 (mTORC1).

FY 2011-12

Summary
The activity of the mammalian target of rapamycin complex 1 (mTORC1) is frequently dysregulated in human diseases characterized by abnormal metabolism and proliferation such as diabetes, cancer and heart disease. Accordingly, compounds modulating the activity of mTORC1 hold great promise for treatments of these diseases. In recent years several of the factors, which mediate the activity of mTORC1 on cellular processes have been uncovered. Notwithstanding these recent advances in the understanding of the mTORC1 pathway, many of the cellular effects of mTORC1 cannot be accounted for by the actions of its known substrates. Thus, to better apprehend the intricate molecular mechanisms underlying the actions of mTORC1, in this proposal we will set out to uncover unknown substrates of mTORC1. To achieve this we will deploy a strategy in which the standard biochemistry and molecular biology techniques will be combined with mass spectrometry. We will further assess how these factors mediate the effects of mTORC1 signaling in normal versus cancer cells using the standard cell and molecular biology and biochemistry techniques. These findings should improve our knowledge of how are mTORC1 signals relayed to cellular processes, which in long-term should open new therapeutic avenues to curb dysregulated mTORC1 signaling in cancer and other human diseases.
Program
CIHR New Investigator
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
241072
Name
Topisirovic Ivan
Region
Québec
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
New Investigators A
Projecttitle
Identification and characterization of novel substrates of the mammalian target of rapamycin complex 1 (mTORC1).
Programtype2
Salary Programs
Orgnameinp2
McGill University
Cihramount2
$300,000
Cihrequipment2
$0
Programname2
CIHR New Investigator
Keyworddelim
4e-Bps; Cancer; Eif4e; Metabolism; Mrna Translation; Mtor; S6 Kinases
Abstract
The activity of the mammalian target of rapamycin complex 1 (mTORC1) is frequently dysregulated in human diseases characterized by abnormal metabolism and proliferation such as diabetes, cancer and heart disease. Accordingly, compounds modulating the activity of mTORC1 hold great promise for treatments of these diseases. In recent years several of the factors, which mediate the activity of mTORC1 on cellular processes have been uncovered. Notwithstanding these recent advances in the understanding of the mTORC1 pathway, many of the cellular effects of mTORC1 cannot be accounted for by the actions of its known substrates. Thus, to better apprehend the intricate molecular mechanisms underlying the actions of mTORC1, in this proposal we will set out to uncover unknown substrates of mTORC1. To achieve this we will deploy a strategy in which the standard biochemistry and molecular biology techniques will be combined with mass spectrometry. We will further assess how these factors mediate the effects of mTORC1 signaling in normal versus cancer cells using the standard cell and molecular biology and biochemistry techniques. These findings should improve our knowledge of how are mTORC1 signals relayed to cellular processes, which in long-term should open new therapeutic avenues to curb dysregulated mTORC1 signaling in cancer and other human diseases.
Competitiondate
201109
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Topisirovic, Ivan
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $300,000~ $0~
McGill University - $300,000 Grant (2011-12) | Canada Spends